Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells

Shih Hsin Tu, Chih Chiang Chang, Ching Shyang Chen, Ka Wai Tam, Ying Jan Wang, Chia Hwa Lee, Hsiao Wei Lin, Tzu Chun Cheng, Ching Shui Huang, Jan Show Chu, Neng Yao Shih, Li Ching Chen, Sy Jye Leu, Yuan Soon Ho, Chih Hsiung Wu

研究成果: 雜誌貢獻文章同行評審

68 引文 斯高帕斯(Scopus)

摘要

Enolase-α (ENO-1) is a key glycolytic enzyme that has been used as a diagnostic marker to identify human lung cancers. To investigate the role of ENO-1 in breast cancer diagnosis and therapy, the mRNA levels of ENO-1 in 244 tumor and normal paired tissue samples and 20 laser capture-microdissected cell clusters were examined by quantitative real-time PCR analysis. Increased ENO-1 mRNA expression was preferentially detected in estrogen receptor-positive (ER+) tumors (tumor/normal ratio >90fold) when compared to ER-negative (tumor/normal ratio >20-fold) tumor tissues. The data presented here demonstrate that those patients whose tumors highly expressed ENO-1 had a poor prognosis with greater tumor size (>2 cm, *P = .017), poor nodal status (N > 3, *P = .018), and a shorter disease-free interval (≤1 year, *P
原文英語
頁(從 - 到)539-553
頁數15
期刊Breast Cancer Research and Treatment
121
發行號3
DOIs
出版狀態已發佈 - 六月 2010

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

指紋 深入研究「Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells」主題。共同形成了獨特的指紋。

引用此